How much cash does ASP Isotopes, Inc. generate?

ASP Isotopes, Inc. (ASPI) generated -$52.4M in operating cash flow over the trailing twelve months.

What is ASP Isotopes, Inc.'s free cash flow?

After $13.5M of capital expenditures, ASP Isotopes, Inc.'s free cash flow was -$65.9M over the trailing twelve months, down 138.3% year over year.

Where does ASP Isotopes, Inc.'s cash flow data come from?

Every line is extracted from ASP Isotopes, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ASP Isotopes, Inc. ASPI Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$158.5M-367%	-$159.84M-393%	-$105.73M-286%	-$100.19M-313%	-$33.92M-72.7%
Depreciation and amortization	$4.82M+833%	$1.91M+306%	$1.02M+121%	$900.25K+214%	$516.79K+267%
Stock-based compensation	$18.55M+112%	$16.02M+87.2%	$13.06M+54.6%	$10.65M+25.9%	$8.74M+5.1%
Deferred income taxes	-$40K—	-$45K—	-$78.68K—	——	——
Provision for credit losses	——	$58K—	$43.5K—	$29K—	$14.5K—
Change in accounts receivable	$1.28M+255%	$482K-4.7%	-$907.76K-1,364%	$128.07K+151%	$361.61K+486%
Change in inventories	——	——	——	——	——
Change in accounts payable	——	——	——	$6.05K—	$249.99K—
Change in accrued liabilities	——	——	$1.47M—	——	——
Change in other assets	-$1.09M—	-$1.22M—	——	——	——
Change in other liabilities	-$1.52M—	-$1.91M—	——	——	——
Net gains (losses) on investments	——	——	——	——	$0—
Non-cash operating lease expense	$3.84M+661%	$676K+42.9%	$579.98K+45.4%	$522.96K+80.3%	$504.34K+171%
Change in operating lease liabilities	-$3.89M-909%	-$695K-62.8%	-$520.66K-26.9%	-$478.48K-64.4%	-$385.3K-117%
Net cash from operating activities	-$52.37M-210%	-$37.78M-126%	-$23.69M-58.0%	-$19.67M-82.1%	-$16.9M-144%
Capital expenditures	$13.48M+25.6%	$9.65M-0.2%	$8.58M-9.6%	$9.91M+74.2%	$10.74M+234%
Acquisitions, net of cash acquired	——	——	——	——	——
Purchases of investments	——	——	——	——	$0—
Purchases of equity securities	——	——	——	——	——
Net cash from investing activities	-$205.62M-1,547%	-$110.79M-874%	-$38.63M-302%	-$41.61M-616%	-$12.49M-274%
Proceeds from issuance of debt	$15.51M+161%	$15.51M+163%	$3.31M-43.8%	$548.05K-90.7%	$5.93M+1,087%
Repayments of debt	$17.33M+2,784%	$15.76M+2,475%	$3.56M+576%	$583.13K+10.8%	$600.86K+71.3%
Proceeds from issuance of common stock	$394.2M+643%	$301.3M+468%	$109.59M+151%	$97.55M—	$53.09M—
Payments for finance leases	$412K—	$378K—	$167.1K—	——	——
Payment of debt issuance costs	——	——	——	——	$0—
Contributions from noncontrolling interests	——	$20.8M—	$15.6M—	$10.4M—	$5.2M—
Net cash from financing activities	$414.99M+569%	$371.6M+350%	$125.18M+69.8%	$100.9M—	$62.05M—
Effect of exchange rate changes on cash	——	——	——	-$199.05K—	-$588.93K—
Net increase (decrease) in cash	$157.01M+381%	$223.03M+309%	$62.86M+28.0%	$39.62M+60.5%	$32.66M—
Net cash from discontinued operations	——	——	——	——	——
Income taxes paid	——	$79K—	$59.25K—	$39.5K—	$19.75K—
Net cash provided by operating activities from discontinued operations	——	——	——	——	——
Deconsolidation Gain Or Loss Amount	——	——	——	——	——
Equity Securities, FV-NI, Gain (Loss)	——	——	——	——	——
Foreign Currency Transaction Gain Loss Before Tax Intercompany	——	——	——	——	——
Foreign currency remeasurement (loss) gain on debt	-$3.8M-11,509%	-$139.95K-300%	$59.49K+150%	-$29.85K-224%	$33.34K+265%
Gain Loss Change In Fair Value Of Convertible Notes Payable	-$123.33M-1,693%	-$123.72M-1,700%	-$66.2M-1,168%	-$69.06M-2,631%	-$6.88M-621%
Gain Loss Change In Fair Value Of Share Liability	——	——	-$660.61K—	-$207.77K—	$98K—
Net income from discontinued operations	——	——	——	——	——
Operating lease liabilities	-$3.89M-909%	-$695K-62.8%	-$520.66K-26.9%	-$478.48K-64.4%	-$385.3K-117%
Current liabilities	-$1.25M—	-$1.91M—	——	——	——
Other long-term liabilities	——	——	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$4.76M—	$2.83M—	——	——	——
Increase Decrease In Receivable From Noncontrolling Interest	——	——	——	——	——
Non Cash Interest Expense On Debt	——	——	——	——	——
Non Cash Lease Income	$131K—	$69K—	$44.54K—	$22.06K—	——
Operating lease right-of-use asset amortization	$3.84M+661%	$676K+42.9%	$579.98K+45.4%	$522.96K+80.3%	$504.34K+171%
Accounts Receivable, Credit Loss Expense (Reversal)	——	$58K—	$43.5K—	$29K—	$14.5K—
Shares Issued For Non Cash Consultant Expense	——	——	——	$1.37M+43.4%	$1.37M+95.9%
Cash Disposed Of Upon Deconsolidation Of Subsidiary	——	——	——	——	——
Payments To Acquire Business Two Net Of Cash Acquired	——	——	——	——	——
Payments to Acquire Equity Securities, FV-NI	——	——	——	——	——
Payments to Acquire Short-Term Investments	——	——	——	——	$0—
Prepaid For Property And Equipment	——	——	——	——	——
Principal collections on finance leases	——	——	——	——	$0—
Cash from (used for) financing activities – discontinued operations	——	——	——	——	——
Distribution To Noncontrolling Interest Of Renergen	——	——	——	——	——
Finance Lease, Principal Payments	$412K—	$378K—	$167.1K—	——	——
Cash Provided by (Used in) Financing Activity, Continuing Operation	——	——	——	——	——
Proceeds From Collection Of Receivable From Noncontrolling Interest In Vie	-$29K-104%	$0-100%	$226-100.0%	$1.6K-99.8%	$736K—
Proceeds from issuances of debt	——	——	——	——	——
Repayments Of Distribution To Noncontrolling Interest In Variable Interest Entities	$622.58K+388%	$403.58K+312%	$441.29K+632%	$150.19K+454%	$127.57K+1,413%
Commission Fee Settled With Common Stock Warrant	——	$0-100%	$191.5K-66.7%	$383K0.0%	$574.5K+200%
Derecognition Of Asset As A Result Of Sales Type Lease	——	——	——	——	——
Increase Decrease In Operating Lease Liability	-$3.89M-909%	-$695K-62.8%	-$520.66K-26.9%	-$478.48K-64.4%	-$385.3K-117%
Non Cash Lease Receivable	$2.08M—	$393K—	$392.59K—	$392.59K—	——
Noncash Consideration For Acquisition	——	——	——	——	——
Purchase Of Property And Equipment Included In Accounts Payable	——	——	——	——	——
Purchase Of Property And Equipment With Bank Loans	——	——	——	——	——
Leased assets obtained in exchange for finance lease liabilities	$653K—	$312K—	——	——	——
Leased assets obtained in exchange for operating lease liabilities	$2.52M—	$851K—	——	——	——
Seller Financed Portion Of Investment In East Coast Nuclear Pharmacy	——	$500K—	$375K—	$250K—	$125K—
Issuance of common stock for the acquisition of Ansys	——	——	——	——	——
Unpaid Financing Fees	——	——	——	——	$0—
Unrealized Gain (Loss) on Investments	——	$17.93M—	$13.45M—	$8.97M—	$4.48M—
Income Taxes Paid, Net	——	$79K—	$59.25K—	$39.5K—	$19.75K—
Free cash flow	-$65.85M-138%	-$47.43M-79.9%	-$32.27M-31.8%	-$29.59M-79.4%	-$27.63M-172%
Free cash flow	-$65.85M-138%	-$47.43M-79.9%	-$32.27M-31.8%	-$29.59M-79.4%	-$27.63M-172%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ASP Isotopes, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does ASP Isotopes, Inc. generate?: ASP Isotopes, Inc. (ASPI) generated -$52.4M in operating cash flow over the trailing twelve months.
What is ASP Isotopes, Inc.'s free cash flow?: After $13.5M of capital expenditures, ASP Isotopes, Inc.'s free cash flow was -$65.9M over the trailing twelve months, down 138.3% year over year.
Where does ASP Isotopes, Inc.'s cash flow data come from?: Every line is extracted from ASP Isotopes, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.